Galectin Therapeutics SEC Filing Effectiveness

Ticker: GALT · Form: EFFECT · Filed: Apr 13, 2026

Sentiment: neutral

Topics: registration-statement, effectiveness

TL;DR

Galectin Therapeutics SEC filing effective 4/13/26. Registration #333-294782.

AI Summary

Galectin Therapeutics Inc. filed an EFFECT form, indicating the effectiveness of a registration statement, on April 13, 2026. The filing relates to registration number 333-294782 and was accepted with accession number 9999999995-26-001150. The company's mailing and business address is 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071.

Why It Matters

This filing signifies that a registration statement for Galectin Therapeutics Inc. has become effective, potentially allowing for the sale of securities.

Risk Assessment

Risk Level: low — This is a routine administrative filing indicating the effectiveness of a registration statement, not a material event like an acquisition or earnings miss.

Key Numbers

Key Players & Entities

FAQ

What type of SEC filing is this?

This is an EFFECT filing, which signifies the effectiveness of a registration statement.

When did this filing become effective?

The filing became effective on April 10, 2026.

What is the SEC accession number for this filing?

The SEC accession number is 9999999995-26-001150.

What is the company's business address?

The company's business address is 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071.

What is the registration file number associated with this filing?

The registration file number is 333-294782.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 13, 2026 regarding GALECTIN THERAPEUTICS INC (GALT).

View full filing on EDGAR

View on Read The Filing